HAMPAO-SPECT of the brain and ocular microangiopathic syndrome in patients infected with the human immunodeficiency virus type 1 by Geier, Stephan A. et al.
Brain HMPAO-SPECT and ocular microangiopathic 
syndrome in H IV -l-infected patients 
Stephan A. Geier*t, Eva Schielke+, Klaus Tatsch§, Ifna Sadri*, 
Johannes R. Bogner*, Gertrud Hammeltt, Karl M. Einhaupl+ 
and Frank D. Goebel* 
Objective: The pathogenesis of neurologic and neuropsychologic dysfunction 
in HIV-1 infection is unclear. The purpose of the study was to determine an 
association between cerebral perfusion and HIV-1-related ocular microangio-
pathic syndrome. 
Methods: We studied 28 HIV-1-infected patients, seven of whom presented 
with asymptomatic HIV infection, nine with lymphadenopathy syndrome or 
AIDS-related complex, and 12 with AIDS. Cerebral perfusion was semi-
quantitatively measured by single photon emission computed tomography of the 
brain using technetium-99 hexamethyl-propylenamine oxime (HMPAO-SPECT). 
The conjunctival manifestation of HIV-1-related microangiopathic syndrome 
was measured by a rating scale determining blood-flow sludging and by 
counting retinal cotton-wool spots. CD4 count, neopterin, ~2-microglobulin 
(~2M), haemoglobin, and age were determined as putative confounding variables. 
Results: Mean conjunctival sludge in patients with normal HMPAO-SPECT 
findings was 1.3±0.5 (mean±s.e.m.); no cotton-wool spots were present. In 
patients with slightly impaired HMPAO-SPECT, it was 2.1 ±0.6 and mean 
cotton-wool spot count was 1.1 ± 0.4. In patients with severely impaired 
HMPAO-SPECT, mean conjunctival sludge was 4.5±0.3 and mean cotton-wool 
spot count was 4.9± 1.1 HMPAO-SPECT findings were closely associated 
with conjunctival sludge (r = 0.72; P< 0.001) and number of cotton-wool spots 
(r = 0.78; P< 0.001), whereas only a slight association with staging of HIV 
disease was found (P= 0.052). Analysis of covariance controlling for CD4 count, 
neopterin, ~2M, age, and haemoglobin demonstrated a significant difference 
between the three HMPAO-SPECT groups for both the number of cotton-wool 
spots (P< 0.001) and the conjunctival sludge rating (P< 0.001). 
Conclusion: There was a close association between severity of HIV-1-related 
ocular microangiopathic syndrome and severity of cerebral hypoperfusion. 
Microvascular alterations might contribute to the pathogenesis of neurological 
and neuropsychological symptoms in patients with HIV-1 disease. Furthermore, 
the conjunctival sludge rating and the number of cotton-wool spots might be 
appropriate indicators for severity of microvascular changes of the central nervous 
system. 
AIDS 1993,7:1589-1594 
Keywords: HIV-related ocular microangiopathic syndrome, microcirculation, 
ocular periusion, cerebral periusion, CD4 count, HIV-1, AIDS, 
AIDS dementia complex. 
From the *Medizinische Poliklinik, tDepartment of Ophthalmology, Klinikum Innenstadt, mepartment of Neurology, 
§Department of Nuclear Medicine, ttlnstitute for Biometrics and Epidemiology, Klinikum GroBhadern, Ludwig-Maximilians-Universitat 
Munchen, Germany. 
Sponsorship: Supported by Bundesministerium fOr Forschung und Technologie, and by Bundesministerium fOr Gesundheit, 
Germany, grant FKZ BGA 1II-002-89/FVP. 
Requests for reprints to: Stephan A. Geier, MD, Dipl-Psych, Medizinische Poliklinik, Klinikum Innenstadt der 
Ludwig-Maximilians-Universitat Munchen, Pettenkoferstr. 8a, 80336 Munich, Germany. 
Date of receipt: 13 April 1993; revised: 6 September 1993; accepted: 21 September 1993. 
© Current Science Ltd ISSN 0269-9370 1589 
1590 AIDS 1993, Vol 7 No 12 
Introduction 
Involvement of the nervous system is a dreaded 
manifestation of HIV-1 infection [1-4]. Neurologic 
or neuropsychologic symptoms are found in at least 
4CH50% of patients with AIDS or HIV-1 disease [5-91. 
However, results on the association between meas-
urements of cognitive function and parameters of 
immunosystemic damage, such as CD4 count or 
~2-microglobulin (~2M), are inconsistent, and the 
pathogenesis of neurologic and neuropsychologic 
symptoms remains unclear [10-15]. 
Clinical studies show a higher risk for cerebral in-
farction or transient neurologic deficits in patients 
with AIDS [16,171. In more than 90010 of all pa-
tients with AIDS, post-mortem studies demonstrate 
abnormalities of the nervous system, and alterations 
of small cerebral vessels have been shown [18-21]. 
Single photon emission computed tomography 
(SPECf) of the brain using technetium-99m hexa-
methyl-propylenamine oxime (HMPAO) is a use-
ful method for imaging regional cerebral blood-flow 
and has become especially interesting in the inves-
tigation of dementia [22,231. HMPAO-SPECT stud-
ies in patients with symptomatic HIV-1 infection 
or AIDS suggested cerebral perfusion abnormalities 
[13,24-28]. 
HIV-1-related ocular microangiopathic syndrome 
was first described by Holland et al. [29] in 1982, 
and represents the most frequent ocular finding in 
patients with HIV-1 disease, including conjuncti-
val and retinal microvascular abnormalities [29-331. 
The conjunctival manifestation is present in approx-
imately 75% of AIDS or AIDS-related complex pa-
tients, including a sludge phenomenon within small 
conjunctival vessels [30,321. The typical retinal mani-
festation are cotton-wool spots visible on ophthal-
moscopy found in 40-700/0 of patients with AIDS 
[29,31,33-35]. 
The purpose of this study was to evaluate the associ-
ation of alterations of HMP AO-SPECf findings with 
parameters of immunosystemic damage and HIV-l-
related ocular microangiopathic syndrome. Our spe-
cific hypothesis was that there is a close association 
between HIV-1-related ocular microangiopathic syn-
drome, especially abnormal blood-flow sludging in 
conjunctival vessels, and HMPAO-SPECT findings. 
Materials and methods 
Subjects 
Twenty-eight male outpatients with confirmed HIV-
1 infection were studied prospectively. Of these, 25 
were homo-bisexual, one reported intravenous drug 
use and heterosexual transmission was reported by 
two. The mean age was 40.6 years (s.d.; 10.8 years; 
range, 24-75 years). According to our study pro-
tocol patients with the following conditions were 
excluded: diabetes mellitus, rheumatic disease, sys-
temic lupus erythematosus, malignant hypertension, 
leukemia, opportunistic infections of the eye or the 
brain at the time of the study. Informed consent 
(both written and verbal) was obtained from all pa-
tients. 
Seven patients presented with asymptomatic HIV 
infection, nine were staged lymphadenopathy-asso-
ciated syndrome/AIDS-related complex (LAS/ ARC), 
and 12 presented with AIDS. Absolute CD4 lym-
phocyte count was determined by two-color flow 
cytometry of whole-blood preparations (FACScan, 
Becton Dickinson, Inc., Heidelberg, Germany) [36]. 
Serum neopterin (Henning, Inc., Berlin, Germany) 
and serum ~2M (Pharmacia, Inc., Uppsala, Sweden) 
were measured by radioimmunoassay. Haemoglobin 
was measured using the cyanohaemiglobin method. 
HMPAO-SPECT 
SPECf was performed using a rotating double head 
gamma camera (Siemens Rota 11; high resolution col-
limator) after intravenous injection of 370-550 MBq 
99m-Tc-HMPAO. The system was connected to a Mi-
croDeltaNax 11/730 computer system. Data were 
collected from 60 projections (360' rotation) in a 
64 x 64 matrix, and images were reconstructed by fil-
tered back-projection. Transverse, sagittal, and coro-
nal slices (slice thickness: 6.0 mm) were processed. 
SPECf findings were semi-quantitatively evaluated 
using the region of interest technique. Six right-over-
left gray matter ratios of corresponding regions were 
calculated in selected transverse slices. A difference 
in ratios of more than 2 s.d. of a control population 
was considered pathologic. Results were classified 
into three groups as follows: 0, normal findings; I, 
one or two areas of decreased activity in two or 
more consecutive slices; 11, three or more areas of 
decreased activity. 
Measuring ocular microangiopathic syndrome 
Ophthalmic examinations were performed blinded 
to the HMPAO-SPECT results including examination 
at the slit-lamp and indirect ophthalmoscopy. Con-
junctival microangiopathy was determined by one 
of the authors (S.A.G) for each eye using a stan-
dardized rating scale: value 0 (no sludge); value 1 
(sludge just visible); value 2 (sludge clearly visible, 
but low); value 3 (moderate sludge); value 4 (strong 
sludge); value 5 (extreme sludge). Rating scales with 
five to six categories show a high reliability and fea-
sibility [37,381. A biomicroscope with a magnification 
factor 32 was used in all patients, and a conjuncti-
val blood-flow sludging score was calculated as the 
mean value of the rating for the right and the left 
eye. 
Fundus examination was performed by indirect oph-
thalmoscopy after dilation of the pupils. A 14-dioptre 
(dpt) lens was used for posterior pole and periph-
eral retina examination. The outer retinal periphery 
was additionally examined using a 20-dpt lens, and, 
if necessary, examination was extended with a 78-
dpt lens at the slit-lamp. The number of cotton-wool 
spots was counted for each eye and combined into 
one score as indicator of severity of retinal microvas-
culopathy. 
Statistical analysis 
Statistical analysis was carried out on a personal 
computer system with use of SPSS/PC + V4.0 (SPSS, 
Inc., Chicago, Illinois, USA). Analysis of variance 
was calculated for the different parameters with 
HMPAO-SPECT findings as independent variable. 
Addressing our specific hypothesis of an associa-
tion between HMPAO-SPECT findings and ocular 
microangioapathic syndrome, analysis of covariance 
was calculated for the dependent variables, con-
junctival sludge and number of cotton-wool spots 
including the other parameters as covariates. Fur-
thermore, a matrix of intercorrelations was calcu-
lated using the Spearman rank-order correlation co-
efficient with the intention of looking for near regu-
lar patterns, and numerical P values for a two-tailed 
approach are reported [39]. 
Results 
HMPAO-SPECT findings were normal in seven pa-
tients, 11 presented with HMPAO-SPECT value I, 
and 10 with HMPAO-SPECT value 11 (Table 1). As-
sociation of HMPAO-SPECT findings with the stag-
ing of HIV-1 disease was almost statistically signif-
icant (likelihood ratio X2 - 9.37; P= 0.052), whereas 
a close association of HMPAO-SPECT findings with 
conjunctival microvasculopathy was found (X2 = 20; 
P<O.OO1). 
Mean conjunctival sludge rating in patients with 
HMPAO-SPECT value 0 was 1.29±0.52 (mean± 
s.e.m.), no cotton-wool spots were present, and 
HMPAO-SPECT, microangiopathy and HIV Geier et al. 1591 
Table 1. HMPAO-SPECT results and its association with HIV-1 dis-
ease stage (n = 28; X2 = 9.37; P= 0.052) and conjunctival microan-
giopathy (X2 = 20; P< 0.001): cross-tabulation. 
HMPAO-
SPECT 
Value 0 
Value I 
Value 11 
Cumulative 
Asymp. 
2 
5 
0 
7 
HIV-1 
disease 
stage 
LAS/ARC 
3 
3 
3 
9 
AIDS 
2 
3 
7 
12 
Conjunctival 
microangiopathy* 
rating 
Oor1 2or3 4 or 5 
4 3 0 
5 2 4 
0 1 9 
9 6 13 
'Conjunctival microangiopathy: patients are divided into three 
groups according to their conjunctival blood-flow sludging score: 
value 0 or 1; value 2 or 3; value 4 or 5. Asymp., asymptomatic; LAS, 
lymphadenopathy-associated syndrome; ARC, AIDS-related com-
plex. 
mean CD4 count was 245.29±73 (Table 2). In pa-
tients with HMPAO-SPECT value I, this rating was 
2.09±0.56, mean count of cotton-wool spots was 
1.09 ± 0.44, and mean CD4 count was 233.36±60.86. 
In the 10 patients with hypoperfusion in three or 
more regions (HMPAO-SPECT value II) mean con-
junctival sludge (4.50±0.31) and mean count of 
cotton-wool spots (4.90± 1.07) were even higher, 
but mean CD4 count was even lower (11.20 ± 49.30). 
Using analysis of variance, significant differences be-
tween the three HMPAO-SPECT groups were found 
for the conjunctival sludge rating (P< 0.001), and the 
number of cotton-wool spots (P< 0.001). A trend 
of a CD4 count decrease is seen, but not signifi-
cant (P= 0.24). In addition, no significant differences 
were found for haemoglobin, neopterin, and ~2M. 
Age as putative confounding variable was not asso-
ciated with HMP AO-SPECT findings. 
The main effect of HMPAO-SPECT remained signif-
icant using analysis of covariance for both conjunc-
tival sludge (P< 0.001) and number of cotton-wool 
spots (P< 0.001) with covariates as follows: CD4 
count, neopterin, ~2M haemoglobin and age. 
Table 2. HMPAO·SPECT results, manifestations of HIV·1-related microangiopathic syndrome, parameters of immunosystemic damage, and 
covariates. 
HMPAO-SPECT 
Value 0 Value I Value 11 ANOVA 
Variable (mean value±s.e.m.) (n=7) (n = 11) (n= 10) P 
Conjunctival sludge 1.29±0.52 2.09±0.56 4.50iO.31 0.0003 
Cotton-wool spots 0.0 1.09±0.44 4.90i1.07 0.0002 
CD4 count (x 106/1) 245.29±73 233.36 ± 60.86 111.20 ±49.30 0.24 
Neopterin (nmol/I) 25.87i2.28 30.96±4.18 30.28i4.11 0.67 
tl2-microglobulin (mg/I) 4.00±0.29 4.50±0.46 3.80iO.27 0.37 
Haemoglobin (g/dl) 12.17±0.59 13.98±0.64 12.42±0.62 0.11 
Age (years) 45.57i5.55 38.82± 3 39.00±2.61 0.38 
HMPAO-SPECT findings: value 0, no area of hypoperfusion; value I, one or two areas of hypoperfusion; Value 11, three or more areas of 
hypoperfusion. ANOVA, analysis of variance. 
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Table 3. Correlations between the variables (n = 28). 
HMPAO·SPECT Age Haemoglobin ~2-microglobulin Neopterin CD4 count 
Cotton-wool 
spots 
Conjunctival sludge 
Cotton-wool spots 
CD4+ count (xl 06/1) 
Neopterin (nmol!!) 
~2-microglobulin (mg!!) 
Haemoglobin (mg!d!) 
Age (years) 
0.72 (P< 0.001) 
0.78 (P<O.OO1) 
-0.38 (P= 0.049) 
0.12 (P> 0.05) 
-0.14 (P> 0.05) 
-0.09 (P> 0.05) 
-0.18 (P> 0.05) 
-0.12 (P> 0.05) 
-0.7 (P> 0.05) 
0.01 (P>0.05) 
0.02 (P>0.05) 
0.29 (P> 0.05 
-0.16 (P> 0.05) 
-0.42 (P= 0.034) 
-0.29 (P>0.05) 
0.57 (P= 0.003) 
-0.20 (P>0.05) 
-0.09 (P> 0.05) 
Intercorrelations of the different variables are sum-
marized in Table 3. There was a close Spearman cor-
relation between conjunctival sludge and number of 
cotton-wool spots (r = 0.86; P< 0.001), as well as be-
tween CD4 count and conjunctival sludge (r = -0.75; 
P< 0.001), or CD4 count and numher of cotton-wool 
spots (r = -0.66; P< 0.001). Correlation of HMPAO-
SPECT results with conjunctival sludge was r - 0.72 
(P< 0.(01), and correlation of HMPAO-SPECT results 
with the number of cotton-wool spots was r = 0.78 
(P<O.OO1). Spearman correlation between HMPAO-
SPECT results and CD4 count was -0.38 (P= 0.049). 
Discussion 
Our results demonstrate a close correlation be-
tween impairment of regional hrain perfusion and 
severity of two different manifestations of HIV -I-re-
lated ocular microangiopathic syndrome, and both 
associations are only slightly confounded by the 
CD4 count. In addition, neither association is con-
founded by serum neopterin levels, serum ~2M lev-
els, haemoglobin levels, or age. 
Conjunctival sludge and cotton-wool spots are the 
most frequent manifestations of HIV-l-related ocu-
lar microangiopathic syndrome [29-341. Conjuncti-
val vascular ahnormalities similar to patients with 
HIV-I infection have been described in sickle cell 
disease [401, chronic myelogenous leukemia [41,421, 
and many other diseases [43,441. However, conjunc-
tival sludge is occasionally a non-specific finding 
in patients without vascular disease. Therefore, we 
have grouped the conjunctival sludge value 1 to-
gether with value O. According to this classifica-
tion, clinically significant conjunctival sludge (val-
ues 2 to 5) was found in 68% of our patients, 
a finding comparable to reports by Teich [301 or 
Engstrom et al. [321. Cotton-wool spots are fluffy 
yellowish-white retinal lesions caused by focal reti-
nal ischemia [45,461. Fundus fluorecein angiography 
in AIDS patients shows microaneurysms frequently 
occurring around cotton-wool spots [471. Recently, 
microaneurysms were also demonstrated in ophthal-
moloscopically normal patients with LAS or ARC 
0.18 (P> 0.05) 
0.18 (P> 0.05) 
-0.16 (P> 0.05) 
0.45 (P= 0.017) 
0.31 (P>O .OS) -0.75 (P<O.OO1) 0.86 (P<0.001) 
0.11 (P> 0.05) -0.66 (P< 0.001) 
-0.28 (P>O.OS) 
[481. Histopathologic studies of small retinal ves-
sels reveal swollen endothelial cells, duplication of 
the hasal lamina, loss of pericytes and endothelial 
cells, immune complex deposits, and vasoconstric-
tion [33,47,49,501. These changes are typically ad-
jacent to cotton-wool spots, suggesting that cotton-
wool spots are caused hy vaso-occlusion or vaso-
constriction [33,501. 
An association of ocular perfusion ahnormalities 
with cerebral perfusion ahnormalities is not re-
stricted to HIV-I disease. Symptomatic microvas-
cular cerehral involvement in patients with ocu-
lar microangiopathy is well documented for auto-
immune diseases such as systemic lupus erythe-
matosus [51,521 and infectious diseases such as 
malaria [531. An association hetween microvascu-
lar disease and peripheral neuropathy has heen 
reported in diabetes mellitus [541 and cerebral mi-
crovascular involvement is discussed [551. 
HMPAO-SPECT studies hy other authors demon-
strate perfusion abnormalities in HIV-I-infected pa-
tients [24-271, but no significant association of 
HMPAO-SPECT findings with the CD4 count was re-
ported by Rosci et al. [131. This finding is partly in 
accordance with our own results showing a signifi-
cant trend using correlation analysis, hut no signif-
icant difference between the three HMPAO-SPECT 
groups. Furthermore, the pattern of associations 
found in our study is comparable to studies sug-
gesting only a minor association of neuropsycho-
logic deficits with parameters of immunosystemic 
damage [15,351. The pathogenesis of HIV-I-related 
microvascular abnormalities in AIDS patients re-
mains unknown. Blood-flow sludging might con-
tribute to the pathogenesis of alterations of vessel 
structure. For example, the delivery of oxygen at 
the capillary level is compromised if sludge in ves-
sels increases [441, and local hypoxia might stimu-
late the formation of microaneurysms similar to pa-
tients with diabetes [56,571. In addition, reduced reti-
nal perfusion pressure in comhination with retinal 
blood-flow sludging in patients with AIDS was oh-
served [58,591. Increased levels of the highly potent 
vasoconstrictor endothelin-I were reported in pa-
tients with retinal ocular microangiopathic changes 
[60,61], suggesting that endothelin-l-related vaso-
constriction might play a role in the pathogenesis 
of HIV-related microangiopathic syndrome. Stud-
ies demonstrating an infection of endothelin cells 
suggest a direct role of HIV-l in the pathogenesis 
of vascular changes [62-65], 
Recently, we demonstrated a close association be-
tween the number of cotton-wool spots and cogni-
tive impairment as well as neuroretinal dysfunction 
[35,66). These findings are consistent with the hy-
pothesis that HIV -I-related microvascular alterations 
contribute to the pathogenesis of neuropsychologi-
cal dysfunction and abnormal HMPAO-SPECT find-
ings. The relevance of this hypothesis is emphasized 
by the finding that the number of cotton-wool spots 
correlates primarily with impairment of short-term 
memory, a function thought to be closely associ-
ated with cerebral perfusion. It should be noted that 
there has been renewed interest in vascular demen-
tia in aged patients [67,68]. However, HIV-l-related 
microangiopathic syndrome should be considered 
as only one factor in the pathogenesis of functional 
cerebral impairment in patients with HIV -1 disease 
[62-64,69-711. Furthermore, the obvious analogy 
of HIV -I-related microangiopathic syndrome with 
microvascular alterations in autoimmune diseases 
needs further consideration, and the study of HIV-
I-related microangiopathic syndrome might help to 
clarify the relevance of autoimmune processes in the 
pathogenesis of AIDS [72,73]. 
In conclusion, the present study suggests that neu-
rologic and neuropsychological deficits in patients 
with HIV-l disease are caused partly by HIV-l-
related microangiopathic syndrome. In this context, 
the determinations of cotton-wool spots or the con-
junctival blood-flow sludge rating might be used as 
indicators of cerebral perfusion abnormalities. Fur-
ther studies are necessary to investigate the patho-
genesis of microvascular lesions of the central and 
peripheral nervous system in patients with HIV in-
fection, and therapeutic implications should be con-
sidered. 
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